News

The multi-centre, open-label, early stopping design study will measure the clinical activity of Tasquinimod by the section of patients with progression free survival at pre-defined time-points. Ipsen R&D

Australian-based Dynamiclear’s product is intended for symptomatic treatment of cold sores and fever blisters in just one application. A 150 patient-based clinical trial showed that by day three

Gonax is designed to inhibit the binding of GnRH, a hormone produced by the hypothalamus in the brain, to the specific receptors thereby restraining the testosterone production and

The European Commission is yet to approve the product that should be used in combination with a clinical evaluation. Amyvid global brand leader Diane Bakaysa said, "If approved

Under the LOI, Abattis has gained rights to acquire the area of BC to a BioPharma license and the Vertical Design’s equipment. Abattis president and CEO Mike Withrow

The collaboration will leverage Fragment Evolution (FE) technology that was developed by Astellas using small molecular weight fragments and the technologies gathered by AIST for the construction of

The new company, CSafe, as result of the merger, is expected to be the only global provider of cold chain solutions including packaging, passive systems, active systems, with

Tris Pharma corporate development vice president Peter Ciano was quoted by NJBIZ as saying that the recently received FDA approval for a product is expected to add another

The cancer drugs will be based on TNI BioTech’s patents covering Methionine Enkephalin. TNI BioTech will carry out pre-clinical and clinical trials in China. The pre-clinical trials will